nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—CYP3A4—Ezetimibe—atherosclerosis	0.122	0.211	CbGbCtD
Temozolomide—CYP3A4—Rosuvastatin—atherosclerosis	0.122	0.211	CbGbCtD
Temozolomide—CYP3A4—Simvastatin—atherosclerosis	0.113	0.196	CbGbCtD
Temozolomide—CYP3A4—Pravastatin—atherosclerosis	0.111	0.192	CbGbCtD
Temozolomide—CYP3A4—Lovastatin—atherosclerosis	0.111	0.192	CbGbCtD
Temozolomide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000833	0.00197	CcSEcCtD
Temozolomide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000832	0.00197	CcSEcCtD
Temozolomide—Vision blurred—Lovastatin—atherosclerosis	0.000832	0.00197	CcSEcCtD
Temozolomide—Mental disorder—Simvastatin—atherosclerosis	0.000831	0.00197	CcSEcCtD
Temozolomide—Tremor—Lovastatin—atherosclerosis	0.000827	0.00196	CcSEcCtD
Temozolomide—Visual impairment—Pravastatin—atherosclerosis	0.000826	0.00195	CcSEcCtD
Temozolomide—Erythema—Simvastatin—atherosclerosis	0.000825	0.00195	CcSEcCtD
Temozolomide—Ill-defined disorder—Lovastatin—atherosclerosis	0.000819	0.00194	CcSEcCtD
Temozolomide—Eye disorder—Niacin—atherosclerosis	0.000814	0.00193	CcSEcCtD
Temozolomide—Tinnitus—Niacin—atherosclerosis	0.000812	0.00192	CcSEcCtD
Temozolomide—Erythema multiforme—Pravastatin—atherosclerosis	0.00081	0.00192	CcSEcCtD
Temozolomide—Dysgeusia—Simvastatin—atherosclerosis	0.000808	0.00191	CcSEcCtD
Temozolomide—Flushing—Niacin—atherosclerosis	0.000808	0.00191	CcSEcCtD
Temozolomide—Angioedema—Lovastatin—atherosclerosis	0.000806	0.00191	CcSEcCtD
Temozolomide—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000803	0.0019	CcSEcCtD
Temozolomide—Anaemia—Ezetimibe—atherosclerosis	0.0008	0.00189	CcSEcCtD
Temozolomide—Tinnitus—Pravastatin—atherosclerosis	0.000799	0.00189	CcSEcCtD
Temozolomide—Malaise—Lovastatin—atherosclerosis	0.000796	0.00188	CcSEcCtD
Temozolomide—Flushing—Pravastatin—atherosclerosis	0.000796	0.00188	CcSEcCtD
Temozolomide—Cardiac disorder—Pravastatin—atherosclerosis	0.000796	0.00188	CcSEcCtD
Temozolomide—Vertigo—Lovastatin—atherosclerosis	0.000793	0.00188	CcSEcCtD
Temozolomide—Angioedema—Ezetimibe—atherosclerosis	0.000791	0.00187	CcSEcCtD
Temozolomide—Angiopathy—Niacin—atherosclerosis	0.00079	0.00187	CcSEcCtD
Temozolomide—Leukopenia—Lovastatin—atherosclerosis	0.00079	0.00187	CcSEcCtD
Temozolomide—Chills—Niacin—atherosclerosis	0.000781	0.00185	CcSEcCtD
Temozolomide—Malaise—Ezetimibe—atherosclerosis	0.000781	0.00185	CcSEcCtD
Temozolomide—Vision blurred—Simvastatin—atherosclerosis	0.000778	0.00184	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000774	0.00183	CcSEcCtD
Temozolomide—Tremor—Simvastatin—atherosclerosis	0.000773	0.00183	CcSEcCtD
Temozolomide—Alopecia—Niacin—atherosclerosis	0.000769	0.00182	CcSEcCtD
Temozolomide—Chills—Pravastatin—atherosclerosis	0.000769	0.00182	CcSEcCtD
Temozolomide—Insomnia—Rosuvastatin—atherosclerosis	0.000769	0.00182	CcSEcCtD
Temozolomide—Ill-defined disorder—Simvastatin—atherosclerosis	0.000766	0.00181	CcSEcCtD
Temozolomide—Palpitations—Ezetimibe—atherosclerosis	0.000765	0.00181	CcSEcCtD
Temozolomide—Paraesthesia—Rosuvastatin—atherosclerosis	0.000763	0.00181	CcSEcCtD
Temozolomide—Anaemia—Simvastatin—atherosclerosis	0.000763	0.00181	CcSEcCtD
Temozolomide—Erythema—Niacin—atherosclerosis	0.000758	0.00179	CcSEcCtD
Temozolomide—Malnutrition—Niacin—atherosclerosis	0.000758	0.00179	CcSEcCtD
Temozolomide—Alopecia—Pravastatin—atherosclerosis	0.000757	0.00179	CcSEcCtD
Temozolomide—Cough—Ezetimibe—atherosclerosis	0.000755	0.00179	CcSEcCtD
Temozolomide—Angioedema—Simvastatin—atherosclerosis	0.000754	0.00178	CcSEcCtD
Temozolomide—Arthralgia—Lovastatin—atherosclerosis	0.000751	0.00178	CcSEcCtD
Temozolomide—Myalgia—Lovastatin—atherosclerosis	0.000751	0.00178	CcSEcCtD
Temozolomide—Anxiety—Lovastatin—atherosclerosis	0.000749	0.00177	CcSEcCtD
Temozolomide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000748	0.00177	CcSEcCtD
Temozolomide—Hypertension—Ezetimibe—atherosclerosis	0.000747	0.00177	CcSEcCtD
Temozolomide—Malaise—Simvastatin—atherosclerosis	0.000744	0.00176	CcSEcCtD
Temozolomide—Discomfort—Lovastatin—atherosclerosis	0.000742	0.00176	CcSEcCtD
Temozolomide—Vertigo—Simvastatin—atherosclerosis	0.000742	0.00175	CcSEcCtD
Temozolomide—Leukopenia—Simvastatin—atherosclerosis	0.000739	0.00175	CcSEcCtD
Temozolomide—Arthralgia—Ezetimibe—atherosclerosis	0.000737	0.00174	CcSEcCtD
Temozolomide—Myalgia—Ezetimibe—atherosclerosis	0.000737	0.00174	CcSEcCtD
Temozolomide—Dry mouth—Lovastatin—atherosclerosis	0.000735	0.00174	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000732	0.00173	CcSEcCtD
Temozolomide—Dysgeusia—Pravastatin—atherosclerosis	0.000731	0.00173	CcSEcCtD
Temozolomide—Discomfort—Ezetimibe—atherosclerosis	0.000728	0.00172	CcSEcCtD
Temozolomide—Pain—Rosuvastatin—atherosclerosis	0.000727	0.00172	CcSEcCtD
Temozolomide—Constipation—Rosuvastatin—atherosclerosis	0.000727	0.00172	CcSEcCtD
Temozolomide—Confusional state—Lovastatin—atherosclerosis	0.000726	0.00172	CcSEcCtD
Temozolomide—Dry mouth—Ezetimibe—atherosclerosis	0.000721	0.00171	CcSEcCtD
Temozolomide—Anaphylactic shock—Lovastatin—atherosclerosis	0.00072	0.0017	CcSEcCtD
Temozolomide—Infection—Lovastatin—atherosclerosis	0.000715	0.00169	CcSEcCtD
Temozolomide—Vision blurred—Niacin—atherosclerosis	0.000714	0.00169	CcSEcCtD
Temozolomide—Confusional state—Ezetimibe—atherosclerosis	0.000712	0.00169	CcSEcCtD
Temozolomide—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000706	0.00167	CcSEcCtD
Temozolomide—Thrombocytopenia—Lovastatin—atherosclerosis	0.000705	0.00167	CcSEcCtD
Temozolomide—Vision blurred—Pravastatin—atherosclerosis	0.000703	0.00166	CcSEcCtD
Temozolomide—Myalgia—Simvastatin—atherosclerosis	0.000703	0.00166	CcSEcCtD
Temozolomide—Arthralgia—Simvastatin—atherosclerosis	0.000703	0.00166	CcSEcCtD
Temozolomide—Infection—Ezetimibe—atherosclerosis	0.000702	0.00166	CcSEcCtD
Temozolomide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.0007	0.00166	CcSEcCtD
Temozolomide—Anxiety—Simvastatin—atherosclerosis	0.0007	0.00166	CcSEcCtD
Temozolomide—Tremor—Pravastatin—atherosclerosis	0.000699	0.00165	CcSEcCtD
Temozolomide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000695	0.00164	CcSEcCtD
Temozolomide—Discomfort—Simvastatin—atherosclerosis	0.000694	0.00164	CcSEcCtD
Temozolomide—Nervous system disorder—Ezetimibe—atherosclerosis	0.000693	0.00164	CcSEcCtD
Temozolomide—Angioedema—Niacin—atherosclerosis	0.000693	0.00164	CcSEcCtD
Temozolomide—Ill-defined disorder—Pravastatin—atherosclerosis	0.000692	0.00164	CcSEcCtD
Temozolomide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000692	0.00164	CcSEcCtD
Temozolomide—Anaemia—Pravastatin—atherosclerosis	0.00069	0.00163	CcSEcCtD
Temozolomide—Anorexia—Lovastatin—atherosclerosis	0.000686	0.00162	CcSEcCtD
Temozolomide—Skin disorder—Ezetimibe—atherosclerosis	0.000686	0.00162	CcSEcCtD
Temozolomide—Angioedema—Pravastatin—atherosclerosis	0.000682	0.00161	CcSEcCtD
Temozolomide—Vertigo—Niacin—atherosclerosis	0.000681	0.00161	CcSEcCtD
Temozolomide—Confusional state—Simvastatin—atherosclerosis	0.000679	0.00161	CcSEcCtD
Temozolomide—Leukopenia—Niacin—atherosclerosis	0.000678	0.00161	CcSEcCtD
Temozolomide—Urticaria—Rosuvastatin—atherosclerosis	0.000675	0.0016	CcSEcCtD
Temozolomide—Oedema—Simvastatin—atherosclerosis	0.000674	0.00159	CcSEcCtD
Temozolomide—Anaphylactic shock—Simvastatin—atherosclerosis	0.000674	0.00159	CcSEcCtD
Temozolomide—Malaise—Pravastatin—atherosclerosis	0.000673	0.00159	CcSEcCtD
Temozolomide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000672	0.00159	CcSEcCtD
Temozolomide—Vertigo—Pravastatin—atherosclerosis	0.00067	0.00159	CcSEcCtD
Temozolomide—Palpitations—Niacin—atherosclerosis	0.00067	0.00158	CcSEcCtD
Temozolomide—Infection—Simvastatin—atherosclerosis	0.000669	0.00158	CcSEcCtD
Temozolomide—Leukopenia—Pravastatin—atherosclerosis	0.000668	0.00158	CcSEcCtD
Temozolomide—Cough—Niacin—atherosclerosis	0.000661	0.00156	CcSEcCtD
Temozolomide—Thrombocytopenia—Simvastatin—atherosclerosis	0.00066	0.00156	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000656	0.00155	CcSEcCtD
Temozolomide—Insomnia—Lovastatin—atherosclerosis	0.000651	0.00154	CcSEcCtD
Temozolomide—Cough—Pravastatin—atherosclerosis	0.000651	0.00154	CcSEcCtD
Temozolomide—Paraesthesia—Lovastatin—atherosclerosis	0.000647	0.00153	CcSEcCtD
Temozolomide—Myalgia—Niacin—atherosclerosis	0.000645	0.00153	CcSEcCtD
Temozolomide—Arthralgia—Niacin—atherosclerosis	0.000645	0.00153	CcSEcCtD
Temozolomide—Hypertension—Pravastatin—atherosclerosis	0.000644	0.00152	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000644	0.00152	CcSEcCtD
Temozolomide—Anorexia—Simvastatin—atherosclerosis	0.000642	0.00152	CcSEcCtD
Temozolomide—Dyspnoea—Lovastatin—atherosclerosis	0.000642	0.00152	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000641	0.00152	CcSEcCtD
Temozolomide—Insomnia—Ezetimibe—atherosclerosis	0.000639	0.00151	CcSEcCtD
Temozolomide—Myalgia—Pravastatin—atherosclerosis	0.000635	0.0015	CcSEcCtD
Temozolomide—Arthralgia—Pravastatin—atherosclerosis	0.000635	0.0015	CcSEcCtD
Temozolomide—Paraesthesia—Ezetimibe—atherosclerosis	0.000634	0.0015	CcSEcCtD
Temozolomide—Dyspepsia—Lovastatin—atherosclerosis	0.000634	0.0015	CcSEcCtD
Temozolomide—Anxiety—Pravastatin—atherosclerosis	0.000633	0.0015	CcSEcCtD
Temozolomide—Dry mouth—Niacin—atherosclerosis	0.000631	0.00149	CcSEcCtD
Temozolomide—Dyspnoea—Ezetimibe—atherosclerosis	0.00063	0.00149	CcSEcCtD
Temozolomide—Discomfort—Pravastatin—atherosclerosis	0.000628	0.00149	CcSEcCtD
Temozolomide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000626	0.00148	CcSEcCtD
Temozolomide—Decreased appetite—Lovastatin—atherosclerosis	0.000626	0.00148	CcSEcCtD
Temozolomide—Dyspepsia—Ezetimibe—atherosclerosis	0.000622	0.00147	CcSEcCtD
Temozolomide—Fatigue—Lovastatin—atherosclerosis	0.000621	0.00147	CcSEcCtD
Temozolomide—Oedema—Niacin—atherosclerosis	0.000619	0.00146	CcSEcCtD
Temozolomide—Anaphylactic shock—Niacin—atherosclerosis	0.000619	0.00146	CcSEcCtD
Temozolomide—Pain—Lovastatin—atherosclerosis	0.000616	0.00146	CcSEcCtD
Temozolomide—Constipation—Lovastatin—atherosclerosis	0.000616	0.00146	CcSEcCtD
Temozolomide—Confusional state—Pravastatin—atherosclerosis	0.000614	0.00145	CcSEcCtD
Temozolomide—Decreased appetite—Ezetimibe—atherosclerosis	0.000614	0.00145	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000614	0.00145	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00061	0.00144	CcSEcCtD
Temozolomide—Asthenia—Rosuvastatin—atherosclerosis	0.00061	0.00144	CcSEcCtD
Temozolomide—Insomnia—Simvastatin—atherosclerosis	0.000609	0.00144	CcSEcCtD
Temozolomide—Oedema—Pravastatin—atherosclerosis	0.000609	0.00144	CcSEcCtD
Temozolomide—Anaphylactic shock—Pravastatin—atherosclerosis	0.000609	0.00144	CcSEcCtD
Temozolomide—Fatigue—Ezetimibe—atherosclerosis	0.000609	0.00144	CcSEcCtD
Temozolomide—Infection—Pravastatin—atherosclerosis	0.000605	0.00143	CcSEcCtD
Temozolomide—Paraesthesia—Simvastatin—atherosclerosis	0.000605	0.00143	CcSEcCtD
Temozolomide—Pain—Ezetimibe—atherosclerosis	0.000604	0.00143	CcSEcCtD
Temozolomide—Constipation—Ezetimibe—atherosclerosis	0.000604	0.00143	CcSEcCtD
Temozolomide—Pruritus—Rosuvastatin—atherosclerosis	0.000601	0.00142	CcSEcCtD
Temozolomide—Skin disorder—Niacin—atherosclerosis	0.000601	0.00142	CcSEcCtD
Temozolomide—Dyspnoea—Simvastatin—atherosclerosis	0.000601	0.00142	CcSEcCtD
Temozolomide—Hyperhidrosis—Niacin—atherosclerosis	0.000598	0.00141	CcSEcCtD
Temozolomide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000596	0.00141	CcSEcCtD
Temozolomide—Feeling abnormal—Lovastatin—atherosclerosis	0.000593	0.0014	CcSEcCtD
Temozolomide—Dyspepsia—Simvastatin—atherosclerosis	0.000593	0.0014	CcSEcCtD
Temozolomide—Anorexia—Niacin—atherosclerosis	0.00059	0.0014	CcSEcCtD
Temozolomide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000589	0.00139	CcSEcCtD
Temozolomide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000589	0.00139	CcSEcCtD
Temozolomide—Decreased appetite—Simvastatin—atherosclerosis	0.000586	0.00139	CcSEcCtD
Temozolomide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000582	0.00138	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000582	0.00138	CcSEcCtD
Temozolomide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000581	0.00138	CcSEcCtD
Temozolomide—Fatigue—Simvastatin—atherosclerosis	0.000581	0.00137	CcSEcCtD
Temozolomide—Anorexia—Pravastatin—atherosclerosis	0.000581	0.00137	CcSEcCtD
Temozolomide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000578	0.00137	CcSEcCtD
Temozolomide—Pain—Simvastatin—atherosclerosis	0.000576	0.00136	CcSEcCtD
Temozolomide—Constipation—Simvastatin—atherosclerosis	0.000576	0.00136	CcSEcCtD
Temozolomide—Urticaria—Lovastatin—atherosclerosis	0.000572	0.00135	CcSEcCtD
Temozolomide—Body temperature increased—Lovastatin—atherosclerosis	0.000569	0.00135	CcSEcCtD
Temozolomide—Abdominal pain—Lovastatin—atherosclerosis	0.000569	0.00135	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000564	0.00133	CcSEcCtD
Temozolomide—Dizziness—Rosuvastatin—atherosclerosis	0.000562	0.00133	CcSEcCtD
Temozolomide—Urticaria—Ezetimibe—atherosclerosis	0.000561	0.00133	CcSEcCtD
Temozolomide—Insomnia—Niacin—atherosclerosis	0.000559	0.00132	CcSEcCtD
Temozolomide—Abdominal pain—Ezetimibe—atherosclerosis	0.000558	0.00132	CcSEcCtD
Temozolomide—Body temperature increased—Ezetimibe—atherosclerosis	0.000558	0.00132	CcSEcCtD
Temozolomide—Paraesthesia—Niacin—atherosclerosis	0.000555	0.00131	CcSEcCtD
Temozolomide—Feeling abnormal—Simvastatin—atherosclerosis	0.000555	0.00131	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000555	0.00131	CcSEcCtD
Temozolomide—Dyspnoea—Niacin—atherosclerosis	0.000551	0.0013	CcSEcCtD
Temozolomide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000551	0.0013	CcSEcCtD
Temozolomide—Insomnia—Pravastatin—atherosclerosis	0.000551	0.0013	CcSEcCtD
Temozolomide—Somnolence—Niacin—atherosclerosis	0.00055	0.0013	CcSEcCtD
Temozolomide—Paraesthesia—Pravastatin—atherosclerosis	0.000547	0.00129	CcSEcCtD
Temozolomide—Dyspepsia—Niacin—atherosclerosis	0.000544	0.00129	CcSEcCtD
Temozolomide—Dyspnoea—Pravastatin—atherosclerosis	0.000543	0.00128	CcSEcCtD
Temozolomide—Decreased appetite—Niacin—atherosclerosis	0.000538	0.00127	CcSEcCtD
Temozolomide—Dyspepsia—Pravastatin—atherosclerosis	0.000536	0.00127	CcSEcCtD
Temozolomide—Rash—Rosuvastatin—atherosclerosis	0.000536	0.00127	CcSEcCtD
Temozolomide—Dermatitis—Rosuvastatin—atherosclerosis	0.000535	0.00127	CcSEcCtD
Temozolomide—Urticaria—Simvastatin—atherosclerosis	0.000535	0.00127	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000534	0.00126	CcSEcCtD
Temozolomide—Abdominal pain—Simvastatin—atherosclerosis	0.000533	0.00126	CcSEcCtD
Temozolomide—Body temperature increased—Simvastatin—atherosclerosis	0.000533	0.00126	CcSEcCtD
Temozolomide—Headache—Rosuvastatin—atherosclerosis	0.000532	0.00126	CcSEcCtD
Temozolomide—Hypersensitivity—Lovastatin—atherosclerosis	0.000531	0.00126	CcSEcCtD
Temozolomide—Decreased appetite—Pravastatin—atherosclerosis	0.000529	0.00125	CcSEcCtD
Temozolomide—Pain—Niacin—atherosclerosis	0.000529	0.00125	CcSEcCtD
Temozolomide—Fatigue—Pravastatin—atherosclerosis	0.000525	0.00124	CcSEcCtD
Temozolomide—Constipation—Pravastatin—atherosclerosis	0.000521	0.00123	CcSEcCtD
Temozolomide—Pain—Pravastatin—atherosclerosis	0.000521	0.00123	CcSEcCtD
Temozolomide—Hypersensitivity—Ezetimibe—atherosclerosis	0.00052	0.00123	CcSEcCtD
Temozolomide—Asthenia—Lovastatin—atherosclerosis	0.000517	0.00122	CcSEcCtD
Temozolomide—Pruritus—Lovastatin—atherosclerosis	0.00051	0.00121	CcSEcCtD
Temozolomide—Asthenia—Ezetimibe—atherosclerosis	0.000507	0.0012	CcSEcCtD
Temozolomide—Gastrointestinal pain—Niacin—atherosclerosis	0.000506	0.0012	CcSEcCtD
Temozolomide—Nausea—Rosuvastatin—atherosclerosis	0.000505	0.00119	CcSEcCtD
Temozolomide—Feeling abnormal—Pravastatin—atherosclerosis	0.000502	0.00119	CcSEcCtD
Temozolomide—Pruritus—Ezetimibe—atherosclerosis	0.0005	0.00118	CcSEcCtD
Temozolomide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000498	0.00118	CcSEcCtD
Temozolomide—Hypersensitivity—Simvastatin—atherosclerosis	0.000496	0.00117	CcSEcCtD
Temozolomide—Diarrhoea—Lovastatin—atherosclerosis	0.000493	0.00117	CcSEcCtD
Temozolomide—Urticaria—Niacin—atherosclerosis	0.000491	0.00116	CcSEcCtD
Temozolomide—Abdominal pain—Niacin—atherosclerosis	0.000489	0.00116	CcSEcCtD
Temozolomide—Body temperature increased—Niacin—atherosclerosis	0.000489	0.00116	CcSEcCtD
Temozolomide—Urticaria—Pravastatin—atherosclerosis	0.000484	0.00114	CcSEcCtD
Temozolomide—Asthenia—Simvastatin—atherosclerosis	0.000483	0.00114	CcSEcCtD
Temozolomide—Diarrhoea—Ezetimibe—atherosclerosis	0.000483	0.00114	CcSEcCtD
Temozolomide—Abdominal pain—Pravastatin—atherosclerosis	0.000481	0.00114	CcSEcCtD
Temozolomide—Body temperature increased—Pravastatin—atherosclerosis	0.000481	0.00114	CcSEcCtD
Temozolomide—Pruritus—Simvastatin—atherosclerosis	0.000477	0.00113	CcSEcCtD
Temozolomide—Dizziness—Lovastatin—atherosclerosis	0.000476	0.00113	CcSEcCtD
Temozolomide—Dizziness—Ezetimibe—atherosclerosis	0.000467	0.00111	CcSEcCtD
Temozolomide—Diarrhoea—Simvastatin—atherosclerosis	0.000461	0.00109	CcSEcCtD
Temozolomide—Vomiting—Lovastatin—atherosclerosis	0.000458	0.00108	CcSEcCtD
Temozolomide—Hypersensitivity—Niacin—atherosclerosis	0.000456	0.00108	CcSEcCtD
Temozolomide—Rash—Lovastatin—atherosclerosis	0.000454	0.00107	CcSEcCtD
Temozolomide—Dermatitis—Lovastatin—atherosclerosis	0.000454	0.00107	CcSEcCtD
Temozolomide—Headache—Lovastatin—atherosclerosis	0.000451	0.00107	CcSEcCtD
Temozolomide—Vomiting—Ezetimibe—atherosclerosis	0.000449	0.00106	CcSEcCtD
Temozolomide—Hypersensitivity—Pravastatin—atherosclerosis	0.000449	0.00106	CcSEcCtD
Temozolomide—Dizziness—Simvastatin—atherosclerosis	0.000445	0.00105	CcSEcCtD
Temozolomide—Rash—Ezetimibe—atherosclerosis	0.000445	0.00105	CcSEcCtD
Temozolomide—Dermatitis—Ezetimibe—atherosclerosis	0.000445	0.00105	CcSEcCtD
Temozolomide—Asthenia—Niacin—atherosclerosis	0.000444	0.00105	CcSEcCtD
Temozolomide—Headache—Ezetimibe—atherosclerosis	0.000443	0.00105	CcSEcCtD
Temozolomide—Pruritus—Niacin—atherosclerosis	0.000438	0.00104	CcSEcCtD
Temozolomide—Asthenia—Pravastatin—atherosclerosis	0.000437	0.00103	CcSEcCtD
Temozolomide—Pruritus—Pravastatin—atherosclerosis	0.000431	0.00102	CcSEcCtD
Temozolomide—Vomiting—Simvastatin—atherosclerosis	0.000428	0.00101	CcSEcCtD
Temozolomide—Nausea—Lovastatin—atherosclerosis	0.000428	0.00101	CcSEcCtD
Temozolomide—Rash—Simvastatin—atherosclerosis	0.000425	0.00101	CcSEcCtD
Temozolomide—Dermatitis—Simvastatin—atherosclerosis	0.000424	0.001	CcSEcCtD
Temozolomide—Diarrhoea—Niacin—atherosclerosis	0.000423	0.001	CcSEcCtD
Temozolomide—Headache—Simvastatin—atherosclerosis	0.000422	0.000999	CcSEcCtD
Temozolomide—Nausea—Ezetimibe—atherosclerosis	0.00042	0.000993	CcSEcCtD
Temozolomide—Diarrhoea—Pravastatin—atherosclerosis	0.000417	0.000986	CcSEcCtD
Temozolomide—Dizziness—Niacin—atherosclerosis	0.000409	0.000968	CcSEcCtD
Temozolomide—Dizziness—Pravastatin—atherosclerosis	0.000403	0.000953	CcSEcCtD
Temozolomide—Nausea—Simvastatin—atherosclerosis	0.0004	0.000947	CcSEcCtD
Temozolomide—Vomiting—Niacin—atherosclerosis	0.000393	0.000931	CcSEcCtD
Temozolomide—Rash—Niacin—atherosclerosis	0.00039	0.000923	CcSEcCtD
Temozolomide—Dermatitis—Niacin—atherosclerosis	0.00039	0.000922	CcSEcCtD
Temozolomide—Headache—Niacin—atherosclerosis	0.000387	0.000917	CcSEcCtD
Temozolomide—Vomiting—Pravastatin—atherosclerosis	0.000387	0.000916	CcSEcCtD
Temozolomide—Rash—Pravastatin—atherosclerosis	0.000384	0.000909	CcSEcCtD
Temozolomide—Dermatitis—Pravastatin—atherosclerosis	0.000384	0.000908	CcSEcCtD
Temozolomide—Headache—Pravastatin—atherosclerosis	0.000382	0.000903	CcSEcCtD
Temozolomide—Nausea—Niacin—atherosclerosis	0.000367	0.000869	CcSEcCtD
Temozolomide—Nausea—Pravastatin—atherosclerosis	0.000362	0.000856	CcSEcCtD
